Figures
Abstract
Introduction
Acoustic-verbal hallucinations (AVH) occur in children and adolescents without psychotic disorders. They are often associated with anxiety, thymic and behavioral disorders and a history of trauma, notably post-traumatic stress disorder (PTSD). AVH may be transient, but their persistence increases the risk of progression to a psychotic disorder. The aim of this study was to observe the links between markers of emotional and social cognition and the presence of AVH in children with PTSD, as well as the evolution of post-traumatic and psychotic symptoms.
Methods
This was a prospective 6-month study, including children aged 8–16 with PTSD and without psychotic disorder (DSM-5). Participants were divided into two groups, with and without AVH. Emotional cognition markers were measured using the DES IV and BAVQ-R, while social cognition markers were assessed via the NEPSY II test.
Results
31 patients were included: 16 with AVH and 15 without. Results showed that at inclusion, markers of emotional and social cognition were not associated with AVH. At 6 months, markers of emotional cognition were significantly associated with the persistence of AVH, PTSD and psychotic disorders, unlike those of social cognition.
Citation: Dumas L-E, Askenazy F, Fernandez A (2025) Relationships between markers of emotional and social cognition and acoustic-verbal hallucinations in children and adolescents with post-traumatic stress disorder (PTSD). PLoS One 20(9): e0332910. https://doi.org/10.1371/journal.pone.0332910
Editor: Mu-Hong Chen, Taipei Veterans General Hospital, TAIWAN
Received: June 26, 2025; Accepted: September 6, 2025; Published: September 23, 2025
Copyright: © 2025 Dumas et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the manuscript and its Supporting information files.
Funding: The author(s) received no specific funding for this work.
Competing interests: The authors have declared that no competing interests exist.
Introduction
Hallucinatory experiences are a symptomatology present in the clinical population apart from a psychotic disorder, organic etiology (metabolic, genetic, infectious, neurological or toxicological) or physiological etiology (such as hypnagogic or hypnopompic hallucinations) [1,2]. These hallucinations are more particularly described in the pediatric population with a prevalence ranging from 17% in 9–12 year olds and 7.5% in 13–18 year olds [3]. They can be multisensory, although acoustic-verbal hallucinations (AVH) are the most reported with a prevalence of 12% in children and adolescents [4–7]. They are linked to the developmental phenomenon of psychic immaturity [8–10] and most often considered transient and benign [8,11].
However, the hallucinatory experience of children and adolescents can be described as associated with thymic, anxiety and behavioral disorders [12,13], a high suicidal risk [14,15] and represent a risk of impairment in the child’s day-to-day functioning [11]. The persistence of hallucinations into adolescence represents a poor psychiatric prognostic factor: hallucinations are more congruent with the disorder with which they are associated [10,16,17] and may progressively evolve into a schizophrenia spectrum disorder [9,18,19].
The literature highlights links between exposure to early trauma and the development of hallucinatory experience [20,21]. AVH in the general population is thought to be closely linked to childhood trauma [22,23], particularly in situations of abuse (physical, psychological and sexual abuse) and neglect [22,24]. Studies show that repeated traumatic events increase the risk of PTSD [25] as well as other psychiatric comorbidities [26] with, in particular, hallucinatory experiences and a risk of progression to a psychotic disorder [27–31]. This clinical evolution is described according to a “continuum” model starting from the traumatic event, the hallucinatory experience and up to the development of psychotic disorder [32].
AVH exists in the pediatric population and may be potentially prodromal to a risk of progression to a psychotic disorder if it is associated with a traumatic context [20,21] and persists over time [9,18,19]. We believe it is necessary to understand the mechanisms at play in this evolution in order to propose targeted preventive management.
The scientific literature reports various cognitive impairments described in PTSD as well as in prodromal hallucinatory experiences of a psychotic disorder [33,34]. PTSD symptoms have been linked to dysfunctions in brain structures involved in the sensory and emotional modulation system [35–37]. Sensory dysregulation may result in hyperreactivity (hypervigilance, flashbacks, freeze response) [38] or hyporeactivity (dissociation, depersonalization, derealization) [39,40]. Emotional and social cognition refers to the set of cognitive processes involved in the recognition, interpretation, and regulation of emotions, as well as in the understanding of others’ mental states (intentions, beliefs, affects), which are essential for appropriate social adaptation [41]. In PTSD, impairments in emotional and social cognition lead to the misattribution of threat to neutral stimuli [42] and to biases in the recognition of others’ intentions and facial expressions [43,44], resulting in developmental and psychosocial difficulties in children and adolescents [45]. Several studies highlight the role of emotional and social cognition in the emergence of psychotic symptoms and in the progression toward schizophrenia spectrum disorders [46,47]. Emotional dysregulation [48,49], along with deficits in theory of mind and affect recognition [1,50], have been proposed as underlying mechanisms of the reality distortion that characterizes hallucinatory experiences [51].
An initial pilot study was carried out by the team from the University Department of Child and Adolescent Psychiatry of the University Pediatric Hospital-Lenval in Nice [52], which found a significant link between the persistence of AVH at 6 months and PTSD (p < 0.05). The study presented here was replicated using the same methodology in a pediatric population with PTSD [53].
In this study we support the hypothesis that markers of emotional and social cognition are involved in the presence and persistence of AVH in children and adolescents with PTSD, as well as during post-traumatic and psychotic symptoms.
The primary objective of our study is to compare emotional and social cognition markers in a population of children and adolescents with PTSD, between those presenting with AVH and those without AVH.
Specifically, we aim to:
- Compare emotional and social cognition markers in a population of children and adolescents with PTSD, between those presenting with persistent auditory AVH at 6-month follow-up and those without AVH at 6 months;
- Assess the correlations between emotional and social cognition markers and the presence of AVH at baseline and their persistence at 6-month follow-up;
- Examine the associations between emotional and social cognition markers and the clinical evolution of PTSD between baseline and 6-month follow-up;
- Investigate the associations between emotional and social cognition markers and the emergence of a psychotic disorder at 6-month follow-up.”
Methods
Study design
This study is a prospective, monocentric, case-control, open-label, and longitudinal biomedical observational protocol conducted over two years. It is taking place at the University Department of Child and Adolescent Psychiatry of the University Pediatric Hospital-Lenval in Nice. The PHYSALIS study was launched on February 8, 2020, and is planned to run for a total of seven years, including a five-year recruitment period followed by a two-year follow-up phase. The current results represent a six-month interim analysis.
Participants
This study is an ancillary study to the protocol entitled “Child and adolescent psychiatry and multidisciplinary research (public health, psychodynamics, neurosciences, and human and social sciences) in children exposed to the Nice attack of July 14, 2016 (Program 14-7).” To facilitate patient recruitment, we requested a revision of the amendment to this ancillary study, allowing the expansion of inclusion criteria to patients with PTSD related to any type of trauma. Participants were children and adolescents treated at the University Department of Child and Adolescent Psychiatry of the University Pediatric Hospital-Lenval (Nice) for a diagnosis of Post Traumatic Stress Disorder (PTSD) (DSM-5).
Inclusion criteria:
- boys and girls aged 8 to 16 years;
- without intellectual deficits (IQ > 70);
- with a diagnosis of PTSD according to DSM-5 criteria (K-SADS-PL).
Exclusion criteria.
- a diagnosis of schizophrenic spectrum disorder according to DSM-5 criteria (K-SADS-PL);
- the presence of genetic, neurological, neurodevelopmental (including autism spectrum disorders) and neurosensory pathologies.
This case-control model observes a population with PTSD. Subjects included are divided into two groups: a “case” group, with the presence of AVH, and a “control” group, without AVH. Participants in both groups will be matched for sex and age (+/- 6 months).
Clinical evaluation tools
Assessment of inclusion and non-inclusion criteria.
The “Post Traumatic Stress Disorder” (PTSD) and “Psychosis” sections of the psychometric Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime (K-SADS-PL) test [54], are conducted in the presence of the child and parents, and used to validate the diagnosis of PTSD and the absence of psychotic disorders. The K-SADS-PL test is a semi-structured diagnostic interview to assess current and past psychopathological episodes in children and adolescents based on DSM-5 criteria, and which is used in a study validating a diagnostic tool for PTSD in a French clinical population [55].
The absence of mental retardation is determined using the abbreviated form of the Wechsler Intelligence Scale for Children (WISC) IV. The French version of the abbreviated form of the WISC IV (Similarities, Picture Concepts, Digit Span, Symbol Search) [56] was administered to screen for intellectual disability (Full Scale IQ < 70) as a non-inclusion criterion; this short form has demonstrated good sensitivity and specificity for screening purposes. The IQ estimate obtained from this abbreviated form was used exclusively for screening and was not included in group comparisons or correlations. All assessments were conducted by the same evaluator trained in test administration by the service’s neuropsychologists.
The psychometric test Mini International Neuropsychiatric Interview Enfants-Adolescents (MINI-Kid) [57], validated in French version [58] explores in a standardized way the main psychiatric disorders of the DSM-5 axis in children. The interview is conducted with the child and his or her parents. The presence of an initial psychiatric disorder is categorized using the MINI-Kid: mood disorder: (depression and emotional dysregulation); anxiety disorder (panic disorder, agoraphobia, social phobia, obsessive-compulsive disorder and generalized anxiety); behavior disorder (conduct disorder, oppositional defiant disorder (ODD) and attention-deficit/hyperactivity disorder (ADHD)).
A sociodemographic and clinical questionnaire, used in a previous study [52], collects information on perinatal, medical, surgical, psychological and psychiatric history, psychomotor development, family history, biographical information and family environment. A specific section is devoted to the clinical description of AVH, excluding hypnopompic and hypnagogic episodes, imaginary productions and companions. This clinical description details the hallucinations, analyzing their characteristics for a qualitative assessment of the symptom: age of onset, clinical type, content, frequency, tone of localization and number of voices heard.
Assessment for group allocation.
The AVH screening questionnaire, used in a previous study [52], classifies participants into “case” or “control” groups. This questionnaire is based on the “Schizophrenia” section of the Diagnostic Interview Schedule for Children-Child (DISC-C) [59,60], two questions of which deal with the presence of AVH. All participants in the study were asked the following question by the evaluator: “Have you ever heard a voice in your head that is different from your own, and that no one else hears but you?” to determine whether they belonged to the “case” or “control” group.
Assessment of the emotional cognition marker.
Emotional cognition is assessed using the Differential Emotion Scale IV (DES IV) [61], in its French version [62]. This self-report scale measures 12 subjective emotional experiences: interest, joy, surprise, anger, contempt, disgust, sadness, fear, guilt, shame, shyness and self-hostility. This instrument measures emotional traits representing stable individual differences, expressed by the frequency with which emotions are experienced by the patient daily. The DES-IV has demonstrated adequate construct validity and acceptable internal consistency for assessing discrete emotions in children and adolescents [63,64].
The Beliefs About Voices Questionnaire-Revised (BAVQ-R) [65,66] is a self-assessment scale that characterizes patients’ relationship with their hallucinations, validated in the French version [67]. The BAVQ-R has shown good internal consistency and satisfactory psychometric properties in both its original [66] and French validated version [68]. It determines whether the voices are omnipotent, benevolent or malevolent. It also explores the subject’s beliefs about the voices and their reaction to them, namely the acceptance of their discourse and/or the ability to resist them. Only patients presenting with AVHs at baseline were able to complete this questionnaire.
Assessment of the social cognition marker.
Social cognition is assessed using the “Theory of Mind” and “Emotion Recognition” tests of the NEPSY II test [69], in French version [70]. The “Theory of Mind” test assesses the child’s ability to understand other perspectives, intentions and beliefs. “Emotion Recognition” assesses the ability to recognize facial effects based on six facial expressions: joy, sadness, anger, fear, disgust and a neutral expression. The NEPSY-II Theory of Mind and Affect Recognition subtests have shown acceptable validity and reliability in pediatric populations [71,72].
All clinical interviews and psychometric assessments, including the K-SADS-PL, MINI-Kid, WISC-IV, NEPSY-II, BAVQ-R, and DES-IV, were administered by the same evaluator, a child and adolescent psychiatrist and PhD student, ensuring both clinical expertise and consistency across all assessments.
Procedures
This study includes two stages: the screening and study assessment performed immediately after inclusion (T0), and a follow-up assessment performed after six months (T1). The study procedure are illustrated in Fig 1.
The study model does not allow blinding because it is a case-control study and the patient’s clinical data contains the question of the presence or absence of AVH at each stage of the protocol. At inclusion, “case” patients were recruited first, and then “control” patients were selected to match them for age and sex. During this study, participants continue their usual child psychiatric follow-up, and other types of treatment can be offered.
Recruitment and consent.
Recruitment was carried out by child psychiatrists from the University Department of Child and Adolescent Psychiatry of the University Pediatric Hospital-Lenval in Nice. Patients are referred to the study evaluator by the referring child psychiatrist. All participants are contacted individually by the experienced and trained evaluator. During screening, patients are informed of study procedures. Before participating in the evaluations, patients and their legal representatives provide signed informed consent.
Inclusion visit (T0).
The inclusion visit was used to determine the inclusion and exclusion criteria for patients referred to the study. The K-SADS-PL and the MINI-Kid were administered, along with the abbreviated version of the WISC-IV. The AVH screening questionnaire was then completed to determine the group in which the patient would be assigned. Finally, emotional cognition tests (DES-IV and BAVQ-R) and social cognition tests (NEPSY-II) were administered.
6-month follow-up visit (T1).
At the 6-month follow-up visit, the AVH screening questionnaire was administered again to all patients in the study to assess the evolution of AVHs, as well as the K-SADS-PL to evaluate changes in PTSD and psychotic disorder diagnoses, and the MINI-Kid.
We redistributed the comparison groups with and without AVHs between T0 and T1. At T0, the “case” and “control” groups corresponded to patients with and without AVHs at the time of inclusion in the study. At T1, the “HAV+” and “HAV–” groups were defined as follows: the “HAV+” group included patients from the initial “case” group whose AVHs persisted at 6 months or patients from the initial “control” group who developed AVHs at 6 months; the “HAV–” group included patients without AVHs at 6 months.
At T1, the patient groups are divided up again for comparison:
- The group of patients with AVH (persistent or appeared within 6 months) (“AVH +” group) and the group of patients without AVH (disappeared or never appeared within 6 months) (“AVH -” group).
- The group of patients with persistent PTSD at 6 months (“PTSD +” group) and the group of patients without PTSD at 6 months (“PTSD -” group).
- The group of patients with a psychotic disorder at 6 months (“Psychosis +” group) and the group of patients without a psychotic disorder at 6 months (“Psychosis -” group).
Statistical analysis
The main objective of the study is a group comparison analysis looking for a significant difference between the “case” and “control” groups at T0. Continuous variables are compared using Student’s t test (or the non-parametric Wilcoxon test if the variables do not follow a normal distribution) and concern the emotional cognition markers “DES IV” and “BAVQ-R”. Categorical variables are compared using the Chi2 test (or Fisher’s non-parametric two-tailed exact test if variables do not follow a normal distribution) and concern the NEPSY II social cognition markers “Theory of Mind” and “Emotion Recognition”. Since there are two primary outcomes, correcting the alpha risk by the Bonferroni method is necessary, with an adjusted alpha of 2.5% for each marker to control the overall familywise error rate.
Concerning secondary objectives:
- 1) A new group comparison analysis is performed at T1 to compare markers of emotional and social cognition between groups with AVH at 6 months (“AVH +” group) and without AVH at 6 months (“AVH -” group).
- 2) A correlation analysis is performed between markers of emotional (DES IV and BAVQ-R) and social (NEPSY II) cognition and:
- the “case” and “control” groups at T0,
- then the “AVH +” and “AVH -” groups at T1.
Pearson’s correlation method was used to measure the association between two continuous variables in a small population sample. For the correlation of categorical variables, the test of nullity of a correlation coefficient (or Spearman’s method in the case where the variables do not follow a normal distribution) is used. The correlations between social cognition and emotional markers and the persistence of AVH in non-psychotic children and adolescents at 6 months are reassessed.
- 3) Emotional and social cognition markers are compared and correlated between:
- groups with PTSD (“PTSD+” group) and without PTSD (“PTSD-” group) at T1,
- then between groups with psychotic disorder (“Psychosis +” group) and without psychotic disorder (“Psychosis-” group) at T1.
Results
Study population
A total of 31 patients were included in the study: 16 patients in the “case” group and 15 patients in the “control” group at T0. The patient population included 80.6% girls and 19.4% boys, with a mean total age of 12.9 years (SD = 2.47). Fig 2 presents the types of trauma experienced by the participants, based on their self-report during the clinical interview (Fig 2). Fig 3 shows the distribution of groups at 6 months (T1) according to the evolution of AVH and the diagnoses of PTSD and psychotic disorder (DSM-5) (Fig 3).
Assessment of markers of emotional and social cognition in AVH at T0 and T1 (Table 1)
Analysis of results at T0.
At T0, social cognition scores measured with the NEPSY-II (Theory of Mind and Emotion Recognition subtests) and emotional cognition scores measured with the DES IV did not differ significantly between the “case” and “control” groups.
Analysis of results at T1.
At T1, there was an evolution of AVH in both groups. In the “case” group, 9 patients still had AVH and 7 reported that they no longer had any. In the “control” group, 4 patients developed AVH within 6 months. A total of 13 patients reported AVH and were combined in the “AVH +” group; 18 patients reported no AVH and were combined in the “AVH -” group (Fig 3). Statistical analyses revealed a significant difference and correlation for the emotional cognition marker. Participants with AVH at T1 had at T0, significantly higher malevolence scores in voices (BAVQ-R) and guilt levels (DES IV) compared with those without AVH at T1 (malevolence: p = 0.04; guilt: p < 0.05). Both malevolence and guilt scores at T0 were also significantly correlated with the presence of AVH at T1 (malevolence: r = 0.36, p = 0.04; guilt: r = 0.35, p < 0.05).
There were no significant results for markers of social cognition. The diagnosis of psychotic disorder at T1 was significantly related (p = 0.01) and correlated (r = 0.45, p = 0.01) to the presence of AVH.
Assessment of emotional and social cognition markers in PTSD at T0 and T1 (Table 2)
At T1, 19 patients still met the PTSD diagnosis and were combined in the “PTSD+” group; 12 patients no longer met the PTSD diagnosis and were combined in the “PTSD-” group (Fig 3). Statistical analyses showed that emotional cognition markers were significantly associated and correlated with PTSD progression at 6 months. Patients without a PTSD diagnosis at 6 months showed significantly omnipotent (p = 0.01 and r = −0.46; p < 0.01) and benevolent (p = 0.01 and r = −0.44; p = 0.01), as well as significant interactions with their AVHs, whether to resist them (p < 0.05 and r = −0.36; p < 0.04) or to adhere to their discourse emotionally (p = 0.03 and r = −0.40; p = 0.02) and behaviorally (p = 0.01 and r = −0.45; p = 0.01). Patients in the “PTSD+” group at T1 showed significant results for the emotions of disgust (p < 0.01), fear (p < 0.01) and anger (p < 0.01). There were no significant differences or correlations for social cognition markers on PTSD progression at 6 months.
Evaluation of markers of emotional and social cognition in psychotic disorder at T0 and T1 (Table 3)
At T1, 4 patients with a diagnosis of psychotic disorder (DSM-5) were grouped together in the “Psychosis +” group (Fig 3): all had significant AVH (p = 0.02 and r = 0.45; p = 0.01) and a diagnosis of PTSD.
Statistical analyses of the “Psychosis +” and “Psychosis -” groups showed no significant relationship or correlation with markers of emotional and social cognition.
Discussion
Our study of children and adolescents with PTSD and AVH sought to identify markers of emotional and social cognition that would help us understand the presence of AVH and the development of post-traumatic and psychotic symptoms.
Emotional impact on the development of hallucinations, PTSD and psychotic disorder
In our study, markers of emotional and social cognition were not associated with AVH present in patients with PTSD at inclusion. However, our results show that emotional cognitions are significantly associated with the presence of AVHs and the diagnosis of PTSD at their T1 reassessment. The malevolent of AVHs, reported by patients at T0, is significantly associated with their presence at T1. These results have already been found in our team’s previous work [73,74]. The scientific literature also reports a negative content of hallucinations in a context of childhood adversity [75,76]. The negative emotional content of hallucinations (threatening, malevolent, hostile voices...) [77,78] is significantly found in patients with an associated psychiatric disorder [79–82] and in particular a psychotic disorder [83]. Guilt is also found in our results to be significantly associated with the presence of AVH at T1 and concurs with other work describing, after trauma, the emotions of shame and guilt that could both encourage the development of AVH and influence their content [84–86].
Our results find that emotions such as disgust, fear and anger are significantly associated with the persistence of the PTSD diagnosis at T1. These emotions are particularly found in the emotional dysregulation present in PTSD [40,87,88] and associated with the risk of progression to comorbid psychiatric pathologies [89,90].
Impact of PTSD on the emotional valence of AVHs
The results of our study show that the presence of AVH at T1 is significantly associated with the perception of malicious hallucinations on the BAVQ-R scale. We also found that patients who no longer had PTSD at T1 significantly perceived these hallucinations as benevolent. These findings are in line with the literature describing the negative content of hallucinations in a trauma context [75,76]. This is described in particular by the fact that hallucinations and trauma share the same negative theme [86,91–94]. Hallucinations here can be seen as the return of fragments of intrusive memories that are non-contextualized and attributed to a source external to the subject [95].
Although AVHs are perceived as benevolent in the subject without PTSD at T1, they nevertheless remain described by the patients in the study as significantly omnipotent in the bond they maintain with it, whether to fight against them or adhere to their discourses. This is in line with the concept described in the literature that AVHs are a defense mechanism for externalizing internal conflicts that are difficult for the subject to mentalize, particularly in children and adolescents with psychic immaturity [10,13,96,97]. AVHs would represent an avoidance strategy for intrusive symptoms by expressing traumatic memories in a different sensory modality [98]. Hallucinations would thus protect patients from PTSD symptoms by encouraging self-protective behavior against them [99].
Evolution of post-traumatic symptoms
Finally, in this study, we found that a 6-month reassessment enabled us to observe an evolution in the symptoms of the patients included: of the 16 patients with AVH at T0, 13 had them at T1, including 4 patients who did not have them at the time of their inclusion in the study. This highlights that hallucinatory experience in the context of psycho-trauma is an evolving symptom [10,50]. Our results highlight a significant link between AVH in PTSD and the development of a psychotic disorder. This is in line with our initial hypothesis placing hallucinatory experience as an evolutionary step in the continuum between psychic trauma and psychotic disorder [87,100]. The literature describes this psychopathological model on the basis of mainly retrospective studies [101]. These findings may suggest a psychopathological framework: in children and adolescents, the presence of AVH could warrant systematic exploration of trauma history, as traumatic experiences may contribute to the content of AVH. Conversely, when PTSD is diagnosed, close monitoring may help identify the possible emergence of perceptual disturbances such as hallucinations, or even progression toward a psychotic disorder. This proposed framework is in line with literature suggesting that psychiatric symptoms often evolve dynamically over time [102,103], gradually leading to comorbid conditions [22,104] and supporting a network-based understanding of psychopathology [105,106]. The originality of this study lies in the prospective analysis of symptom progression, highlighting markers of emotional cognition as a risk factor for poor progression and the target of specific preventive care.
Limitations
This study is a follow-up to an initial pilot study on AVH in non-psychotic children and adolescents. This study was conducted at a single center on a small patient sample (N = 31), which limits the robustness of the conclusions when comparing groups with AVHs (N = 16) and without AVHs (N = 15) over a short follow-up period (6 months), thereby complicating the interpretation of the results. Moreover, this study includes patients covering a wide developmental age range, during which hallucinatory symptomatology shows clinical and prognostic variability. The standard deviation of 2.47 for a mean age of 12.9 years remains moderate in this context. The theme of these studies, although particularly important for understanding the psychopathological mechanisms at play between psycho-trauma, hallucinatory experience and psychotic disorder, presents feasibility difficulties. Hallucinations in non-psychotic children and adolescents are a symptomatology not easily accessible to untrained clinicians. Screening must be targeted, with specific clinical features on questioning to clearly differentiate traumatic reliving from hallucinations. Also, the number of patients included in the study remains small sample sizes.
This study did not include a comparison between the AVH+ and AVH– groups regarding the objective nature or severity of the traumatic events, as our inclusion criterion was based on meeting DSM-5 diagnostic criteria for PTSD, which emphasizes the subjective experience of trauma [107]. In addition, no data were collected on the exact time elapsed between the traumatic event and study inclusion, particularly as many participants reported complex or repeated trauma exposures over time, and PTSD decompensation could occur following a later event rather than the initial one. These factors should be considered as limitations of the present study.
In our study, no significant differences were observed for social cognition markers. Previous studies, however, have reported impairments in social cognition among youth at risk of psychosis and in PTSD populations, suggesting a potential mediating role of social cognition between trauma exposure and subsequent psychopathology, even before the onset of the first psychotic symptoms [46,47,108,109]. At the same time, other studies have not retained social cognition as a consistent vulnerability marker for psychotic symptomatology [110], supporting instead the hypothesis of neurodevelopmental differences in social cognition between individuals progressing to schizophrenia spectrum disorders and those experiencing only isolated psychotic symptoms [111,112]. Furthermore, we can discuss the choice of assessment tools for emotional and social cognition markers in our studies. There are still few validated tools for assessing emotional and social cognition in the pediatric population [113]. The DES-IV and the BAVQ-R are not validated in pediatric populations, and the NEPSY-II presents certain limitations, particularly in the way tasks are administered [103]. All assessments were conducted by an expert examiner, allowing adaptation to the characteristics of the study population. Finally, scientific work proposing a developmental approach to the impairment of social cognition in psycho-trauma reports that this impairment would depend on the conditions of the event, the moment when it took place contemporary with a “pivotal” period in the child’s cognitive development, and the length of time needed to objectify cognitive impairment after the trauma [108,114]. It will thus be necessary to complete the study to determine the association of social cognition on AVH in children and adolescents with PTSD.
Conclusion
Markers of emotional cognition are significantly associated with the presence and persistence of AVH in children and adolescents with PTSD, as well as in the course of post-traumatic and psychotic symptoms. Emotional cognition acts as a common marker for PTSD and hallucinatory experience, reinforcing the notion of a continuum between psycho-trauma and psychotic disorder. This prospective study highlights both fluctuating post-traumatic and hallucinatory symptomatology, and a highly significant association between AVH and the risk of progressing to a diagnosis of psychosis at 6 months. Thus, while post-traumatic symptomatology may not be initially fixed, the presence of AVH may represent a risk factor for poor evolution towards a psychotic disorder. Emotional cognition is thus emerging as a target area for psychopathological and therapeutic understanding in patients with PTSD, to prevent progression to psychotic symptoms.
Acknowledgments
The authors would like to acknowledge the contributors of the study, Foundation Lenval, Pediatric Hospitals of Nice CHU-Lenval and CoBTeK Laboratory and the Nice Pediatric Psychotrauma Center (NPPC).
References
- 1. Jardri R, Bartels-Velthuis AA, Debbané M, Jenner JA, Kelleher I, Dauvilliers Y, et al. From phenomenology to neurophysiological understanding of hallucinations in children and adolescents. Schizophr Bull. 2014;40(Suppl 4):S221-32. pmid:24936083
- 2.
Langlois T. Hallucinations. In: Hallucinations. Dunod; 2020.
- 3. Kelleher I, Connor D, Clarke MC, Devlin N, Harley M, Cannon M. Prevalence of psychotic symptoms in childhood and adolescence: a systematic review and meta-analysis of population-based studies. Psychol Med. 2012;42(9):1857–63. pmid:22225730
- 4. Medjkane F, Notredame C-E, Sharkey L, D’Hondt F, Vaiva G, Jardri R. Association between childhood trauma and multimodal early-onset hallucinations. Br J Psychiatry. 2020;216(3):156–8. pmid:31902385
- 5. Sikich L. Diagnosis and evaluation of hallucinations and other psychotic symptoms in children and adolescents. Child Adolesc Psychiatr Clin N Am. 2013;22(4):655–73. pmid:24012079
- 6. Pilowsky T, Yirmiya N, Arbelle S, Mozes T. Theory of mind abilities of children with schizophrenia, children with autism, and normally developing children. Schizophr Res. 2000;42(2):145–55. pmid:10742652
- 7. Pignon B, Geoffroy PA, Gharib A, Thomas P, Moutot D, Brabant W, et al. Very early hallucinatory experiences: a school-based study. J Child Psychol Psychiatry. 2018;59(1):68–75. pmid:28699661
- 8. Rubio JM, Sanjuán J, Flórez-Salamanca L, Cuesta MJ. Examining the course of hallucinatory experiences in children and adolescents: a systematic review. Schizophr Res. 2012;138(2–3):248–54. pmid:22464200
- 9. Bartels-Velthuis AA, Wigman JTW, Jenner JA, Bruggeman R, van Os J. Course of auditory vocal hallucinations in childhood: 11-year follow-up study. Acta Psychiatr Scand. 2016;134(1):6–15. pmid:27009572
- 10. Maijer K, Palmen SJMC, Sommer IEC. Children seeking help for auditory verbal hallucinations; who are they?. Schizophr Res. 2017;183:31–5. pmid:28277308
- 11. Bartels-Velthuis AA, Jenner JA, van de Willige G, van Os J, Wiersma D. Prevalence and correlates of auditory vocal hallucinations in middle childhood. Br J Psychiatry. 2010;196(1):41–6. pmid:20044659
- 12. Maijer K, Begemann MJH, Palmen SJMC, Leucht S, Sommer IEC. Auditory hallucinations across the lifespan: a systematic review and meta-analysis. Psychol Med. 2017;1–10.
- 13. Healy C, Brannigan R, Dooley N, Coughlan H, Clarke M, Kelleher I, et al. Childhood and adolescent psychotic experiences and risk of mental disorder: a systematic review and meta-analysis. Psychol Med. 2019;49(10):1589–99. pmid:31088578
- 14. Fujita J, Takahashi Y, Nishida A, Okumura Y, Ando S, Kawano M, et al. Auditory verbal hallucinations increase the risk for suicide attempts in adolescents with suicidal ideation. Schizophr Res. 2015;168(1–2):209–12. pmid:26232867
- 15. Lindgren M, Manninen M, Kalska H, Mustonen U, Laajasalo T, Moilanen K, et al. Suicidality, self-harm and psychotic-like symptoms in a general adolescent psychiatric sample. Early Interv Psychiatry. 2017;11(2):113–22. pmid:25582971
- 16. Schimmelmann BG, Michel C, Martz-Irngartinger A, Linder C, Schultze-Lutter F. Age matters in the prevalence and clinical significance of ultra-high-risk for psychosis symptoms and criteria in the general population: Findings from the BEAR and BEARS-kid studies. World Psychiatry. 2015;14(2):189–97. pmid:26043337
- 17. Kelleher I, Lynch F, Harley M, Molloy C, Roddy S, Fitzpatrick C, et al. Psychotic symptoms in adolescence index risk for suicidal behavior: findings from 2 population-based case-control clinical interview studies. Arch Gen Psychiatry. 2012;69(12):1277–83. pmid:23108974
- 18. Poulton R, Caspi A, Moffitt TE, Cannon M, Murray R, Harrington H. Children’s self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study. Arch Gen Psychiatry. 2000;57(11):1053–8. pmid:11074871
- 19. Dominguez MDG, Wichers M, Lieb R, Wittchen H-U, van Os J. Evidence that onset of clinical psychosis is an outcome of progressively more persistent subclinical psychotic experiences: an 8-year cohort study. Schizophr Bull. 2011;37(1):84–93. pmid:19460881
- 20. Read J, van Os J, Morrison AP, Ross CA. Childhood trauma, psychosis and schizophrenia: a literature review with theoretical and clinical implications. Acta Psychiatr Scand. 2005;112(5):330–50.
- 21. Varese F, Barkus E, Bentall RP. Dissociation mediates the relationship between childhood trauma and hallucination-proneness. Psychol Med. 2012;42(5):1025–36. pmid:21896238
- 22. Abajobir AA, Kisely S, Scott JG, Williams G, Clavarino A, Strathearn L, et al. Childhood Maltreatment and Young Adulthood Hallucinations, Delusional Experiences, and Psychosis: A Longitudinal Study. Schizophr Bull. 2017;43(5):1045–55. pmid:28338760
- 23. McCarthy-Jones S. Voices from the storm: a critical review of quantitative studies of auditory verbal hallucinations and childhood sexual abuse. Clin Psychol Rev. 2011;31(6):983–92. pmid:21736865
- 24. Daalman K, Diederen KMJ, Derks EM, van Lutterveld R, Kahn RS, Sommer IEC. Childhood trauma and auditory verbal hallucinations. Psychol Med. 2012;42(12):2475–84. pmid:22716897
- 25. Wilker S, Pfeiffer A, Kolassa S, Koslowski D, Elbert T, Kolassa I-T. How to quantify exposure to traumatic stress? Reliability and predictive validity of measures for cumulative trauma exposure in a post-conflict population. Eur J Psychotraumatol. 2015;6:28306. pmid:26589255
- 26. Karam EG, Friedman MJ, Hill ED, Kessler RC, McLaughlin KA, Petukhova M, et al. Cumulative traumas and risk thresholds: 12-month PTSD in the World Mental Health (WMH) surveys. Depress Anxiety. 2014;31(2):130–42. pmid:23983056
- 27. Whitfield CL, Dube SR, Felitti VJ, Anda RF. Adverse childhood experiences and hallucinations. Child Abuse Negl. 2005;29(7):797–810. pmid:16051353
- 28. Varese F, Smeets F, Drukker M, Lieverse R, Lataster T, Viechtbauer W, et al. Childhood adversities increase the risk of psychosis: a meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr Bull. 2012;38(4):661–71. pmid:22461484
- 29. Bell CJ, Foulds JA, Horwood LJ, Mulder RT, Boden JM. Childhood abuse and psychotic experiences in adulthood: findings from a 35-year longitudinal study. Br J Psychiatry. 2019;214(3):153–8. pmid:30774061
- 30. Levine SZ, Levav I, Yoffe R, Pugachova I. The effects of pre-natal-, early-life- and indirectly-initiated exposures to maximum adversities on the course of schizophrenia. Schizophr Res. 2014;158(1–3):236–40. pmid:25059202
- 31. Aas M, Andreassen OA, Aminoff SR, Færden A, Romm KL, Nesvåg R, et al. A history of childhood trauma is associated with slower improvement rates: Findings from a one-year follow-up study of patients with a first-episode psychosis. BMC Psychiatry. 2016;16:126. pmid:27146044
- 32. Luhrmann TM. Diversity Within the Psychotic Continuum. Schizophr Bull. 2017;43(1):27–31. pmid:27872266
- 33. Seriès P, Veerapa E, Jardri R. Can computational models help elucidate the link between complex trauma and hallucinations?. Schizophr Res. 2024;265:66–73. pmid:37268452
- 34. Le Bellego M, Chaste P, Dzierzynski N. Auditory illusions and Post-traumatic stress disorder: Sound test in a case-control study. J Psychiatr Res. 2024;178:88–93. pmid:39128220
- 35. Fleming LL, Harnett NG, Ressler KJ. Sensory alterations in post-traumatic stress disorder. Curr Opin Neurobiol. 2024;84:102821. pmid:38096758
- 36. Dvir Y, Denietolis B, Frazier JA. Childhood trauma and psychosis. Child Adolesc Psychiatr Clin N Am. 2013;22(4):629–41. pmid:24012077
- 37. Fitzgerald JM, DiGangi JA, Phan KL. Functional Neuroanatomy of Emotion and Its Regulation in PTSD. Harv Rev Psychiatry. 2018;26(3):116–28. pmid:29734226
- 38. Yochman A, Pat-Horenczyk R. Sensory Modulation in Children Exposed to Continuous Traumatic Stress. J Child Adolesc Trauma. 2019;13(1):93–102. pmid:32318232
- 39. Acevedo B, Aron E, Pospos S, Jessen D. The functional highly sensitive brain: a review of the brain circuits underlying sensory processing sensitivity and seemingly related disorders. Philos Trans R Soc Lond B Biol Sci. 2018;373(1744):20170161. pmid:29483346
- 40. Kearney BE, Lanius RA. The brain-body disconnect: A somatic sensory basis for trauma-related disorders. Front Neurosci [Internet]. 2022 [cité 11 mai 2024];16. Disponible sur: https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2022.1015749/full
- 41. Adolphs R. The social brain: neural basis of social knowledge. Annu Rev Psychol. 2009;60:693–716. pmid:18771388
- 42. Harricharan S, McKinnon MC, Lanius RA. How Processing of Sensory Information From the Internal and External Worlds Shape the Perception and Engagement With the World in the Aftermath of Trauma: Implications for PTSD. Front Neurosci [Internet]. 16 avr 2021 [cité 11 mai 2024];15. Disponible sur: https://www.frontiersin.org/journals/neuroscience/articles/10.3389/fnins.2021.625490/full
- 43. Nazarov A, Frewen P, Parlar M, Oremus C, MacQueen G, McKinnon M, et al. Theory of mind performance in women with posttraumatic stress disorder related to childhood abuse. Acta Psychiatr Scand. 2014;129(3):193–201. pmid:23662597
- 44. Plana I, Lavoie M-A, Battaglia M, Achim AM. A meta-analysis and scoping review of social cognition performance in social phobia, posttraumatic stress disorder and other anxiety disorders. J Anxiety Disord. 2014;28(2):169–77. pmid:24239443
- 45. Powers A, Etkin A, Gyurak A, Bradley B, Jovanovic T. Associations Between Childhood Abuse, Posttraumatic Stress Disorder, and Implicit Emotion Regulation Deficits: Evidence From a Low-Income, Inner-City Population. Psychiatry [Internet]. 2015 [cité 26 juin 2024];78(3). Disponible sur: https://pubmed.ncbi.nlm.nih.gov/26391833/
- 46. Cotter J, Bartholomeusz C, Papas A, Allott K, Nelson B, Yung AR, et al. Examining the association between social cognition and functioning in individuals at ultra-high risk for psychosis. Aust N Z J Psychiatry. 2017;51(1):83–92.
- 47. Lee TY, Hong SB, Shin NY, Kwon JS. Social cognitive functioning in prodromal psychosis: a meta-analysis. Schizophr Res. 2015;164(1):28–34.
- 48. Bartels-Velthuis AA, van de Willige G, Jenner JA, Wiersma D, van Os J. Auditory hallucinations in childhood: associations with adversity and delusional ideation. Psychol Med. 2012;42(3):583–93. pmid:21861954
- 49. Trotta A, Murray RM, Fisher HL. The impact of childhood adversity on the persistence of psychotic symptoms: a systematic review and meta-analysis. Psychol Med. 2015;45(12):2481–98. pmid:25903153
- 50. Maijer K, Hayward M, Fernyhough C, Calkins ME, Debbané M, Jardri R, et al. Hallucinations in Children and Adolescents: An Updated Review and Practical Recommendations for Clinicians. Schizophr Bull. 2019;45(45 Suppl 1):S5–23. pmid:30715540
- 51. van Rossum I, Dominguez M-G, Lieb R, Wittchen H-U, van Os J. Affective dysregulation and reality distortion: a 10-year prospective study of their association and clinical relevance. Schizophr Bull. 2011;37(3):561–71. pmid:19793794
- 52. Dumas LE, Bonnard-Couton V, Golse B, Askénazy F. Identification de marqueurs sociaux et émotionnels associés à l’hallucination acoustico-verbale (HAV) en population pédiatrique: étude Physalis. L’Encéphale. 5 Oct 2021.
- 53. Dumas L-E, Fernandez A, Auby P, Askenazy F. Relationship between social cognition and emotional markers and acoustic-verbal hallucination in youth with post-traumatic stress disorder: Protocol for a prospective, 2-year, longitudinal case-control study. PLoS One. 2024;19(7):e0306338. pmid:38954699
- 54.
Kaufman J, Birmaher B, Axelson D, Perepletchikova F, Brent D. K-SADS-PL DSM 5. Child and Andolescent Research and Education, Program Yale University. 2016.
- 55. Gindt M, Richez A, Battista M, Fabre R, Thümmler S, Fernandez A, et al. Validation of the French Version of the Child Posttraumatic Stress Checklist in French School-Aged Children. Front Psychiatry. 2021;12:678916.
- 56.
Grégoire J. Forme abrége du WISC IV. In: L’examen clinique de l’intelligence de l’enfant Fondements et pratique du WISC IV (2ème édition revue et complétée). Wavre, Belgique: Mardaga; 2009. p. 176.
- 57. Sheehan DV, Sheehan KH, Shytle RD, Janavs J, Bannon Y, Rogers JE, et al. Reliability and validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID). J Clin Psychiatry. 2010;71(3):313–26. pmid:20331933
- 58.
Hergueta W. MINI-S: mini international neuropsychiatric interview, simplified for DSM-5 french version 1.2. 2017.
- 59.
Costello A, Edelbrock C, Dulcan MK, Kalas R, Klaric SH. Development and Testing of the NIMH Diagnostic Interview Schedule for Children in a Clinic Population. Final Report (contract RFP-DB-81–0027). Rockville, MD: Center for Epidemiologic Studies, NIMH; 1984.
- 60. Costello EJ, Edelbrock CS, Costello AJ. Validity of the NIMH Diagnostic Interview Schedule for Children: a comparison between psychiatric and pediatric referrals. J Abnorm Child Psychol. 1985;13(4):579–95. pmid:4078188
- 61.
Izard CE, Dougherty FE, Bloxom BM, Kotsch NE. The Differential Emotions Scale: A Method of Measuring the Subjective Experience of Discrete Emotions. Nashville, Tenn: Vanderbilt University Press; 1974.
- 62. Ouss L, Carton S, Jouvent R, Widlöcher D. French translation and validation of Izard’s differential emotion scale. Study of the verbal qualification of emotions. Encephale. 1990;16(6):453–8. pmid:2101784
- 63.
Izard CE. The Psychology of Emotions. Springer Science & Business Media; 1991. p. 476.
- 64.
Izard CE. Organizational and motivational functions of discrete emotions. In: Lewis M, Haviland JM, editors. Handbook of emotions. New York, NY, US: Guilford Press. 1993. p. 631–41.
- 65. Birchwood M, Chadwick P. The omnipotence of voices: testing the validity of a cognitive model. Psychol Med. 1997;27(6):1345–53. pmid:9403906
- 66. Chandwick P, Lees S, Birchwood M. The revised Beliefs About Voices Questionnaire (BAVQ-R). Br J Psychiatry. 2000;177:229–32. pmid:11040883
- 67.
Vavasseur-Desperriers J. Evaluation du rapport aux voix dans la schizophrénie: validation de la version française de l’échelle « Revised Beliefs About Voices Questionnaire » - BAVQR. 2007. p. 238.
- 68. Zanello A, Badan Bâ M. Validation de la version française du « Beliefs About Voices Questionnaire–Revised » (BAVQ-R). L’Encéphale. 2016;42(4):320–4.
- 69. Schmitt AJ, Wodrich DL. Validation of a Developmental Neuropsychological Assessment (NEPSY) through comparison of neurological, scholastic concerns, and control groups. Arch Clin Neuropsychol. 2004;19(8):1077–93. pmid:15533698
- 70.
Korkman M, Kemp SL, Kirk U, Lepoutre D. NEPSY-II- Bilan neuropsychologique de l’enfant - 2nde édition. Éditions du Centre de psychologie appliquée. Montreuil: Pearson; 2012.
- 71.
Korkman M, Kirk U, Kemp S. NEPSY II: clinical and interpretive manual. San Antonio, TX: Harcourt Assessment, PsychCorp; 2007.
- 72. Schworer EK, Hoffman EK, Esbensen AJ. Psychometric Evaluation of Social Cognition and Behavior Measures in Children and Adolescents with Down Syndrome. Brain Sci. 2021;11(7):836. pmid:34202453
- 73. Askenazy FL, Lestideau K, Meynadier A, Dor E, Myquel M, Lecrubier Y. Auditory hallucinations in pre-pubertal children. A one-year follow-up, preliminary findings. Eur Child Adolesc Psychiatry. 2007;16(6):411–5. pmid:17468968
- 74. Askenazy F, Dupuis G, Dor E, Lestideau K, Meynadier A, Myquel M. Clinique des hallucinations auditives chez l’enfant non psychotique. Neuropsychiatr Enfance Adolesc. 2009;57(1):25–31.
- 75. Rosen C, McCarthy-Jones S, Jones N, Chase KA, Sharma RP. Negative voice-content as a full mediator of a relation between childhood adversity and distress ensuing from hearing voices. Schizophr Res. 2018;199:361–6. pmid:29580740
- 76. Scott M, Rossell SL, Meyer D, Toh WL, Thomas N. Childhood trauma, attachment and negative schemas in relation to negative auditory verbal hallucination (AVH) content. Psychiatry Res. 2020;290:112997. pmid:32470717
- 77. Nayani TH, David AS. The auditory hallucination: a phenomenological survey. Psychol Med. 1996;26(1):177–89. pmid:8643757
- 78. Copolov DL, Mackinnon A, Trauer T. Correlates of the affective impact of auditory hallucinations in psychotic disorders. Schizophr Bull. 2004;30(1):163–71. pmid:15176770
- 79. Anketell C, Dorahy MJ, Curran D. A preliminary qualitative investigation of voice hearing and its association with dissociation in chronic PTSD. J Trauma Dissociation. 2011;12(1):88–101. pmid:21240740
- 80. Jessop M, Scott J, Nurcombe B. Hallucinations in adolescent inpatients with post-traumatic stress disorder and schizophrenia: similarities and differences. Australas Psychiatry. 2008;16(4):268–72. pmid:18608156
- 81. Larøi F, Sommer IE, Blom JD, Fernyhough C, Ffytche DH, Hugdahl K, et al. The characteristic features of auditory verbal hallucinations in clinical and nonclinical groups: state-of-the-art overview and future directions. Schizophr Bull. 2012;38(4):724–33. pmid:22499783
- 82. Waters F, Fernyhough C. Hallucinations: A Systematic Review of Points of Similarity and Difference Across Diagnostic Classes. Schizophr Bull. 2017;43(1):32–43. pmid:27872259
- 83. Daalman K, Boks MPM, Diederen KMJ, de Weijer AD, Blom JD, Kahn RS, et al. The same or different? A phenomenological comparison of auditory verbal hallucinations in healthy and psychotic individuals. J Clin Psychiatry. 2011;72(3):320–5. pmid:21450152
- 84. McCarthy-Jones S, Trauer T, Mackinnon A, Sims E, Thomas N, Copolov DL. A new phenomenological survey of auditory hallucinations: evidence for subtypes and implications for theory and practice. Schizophr Bull. 2014;40(1):231–5. pmid:23267192
- 85. McCarthy-Jones S. Post-Traumatic Symptomatology and Compulsions as Potential Mediators of the Relation Between Child Sexual Abuse and Auditory Verbal Hallucinations. Behav Cogn Psychother. 2017:1–14.
- 86. Corstens D, Longden E. The origins of voices: Links between life history and voice hearing in a survey of 100 cases. Psychos Psychol Soc Integr Approach. 2013;5(3):270–85.
- 87. Hardy A. Pathways from Trauma to Psychotic Experiences: A Theoretically Informed Model of Posttraumatic Stress in Psychosis. Front Psychol. 2017;8:697. pmid:28588514
- 88. Dvir Y, Ford JD, Hill M, Frazier JA. Childhood maltreatment, emotional dysregulation, and psychiatric comorbidities. Harv Rev Psychiatry. 2014;22(3):149–61.
- 89. Russo M, Mahon K, Shanahan M, Solon C, Ramjas E, Turpin J, et al. The association between childhood trauma and facial emotion recognition in adults with bipolar disorder. Psychiatry Res. 2015;229(3):771–6. pmid:26272021
- 90. Nicol K, Pope M, Hall J. Facial emotion recognition in borderline personality: an association, with childhood experience. Psychiatry Res. 2014;218(1–2):256–8. pmid:24809243
- 91. Hardy A, Fowler D, Freeman D, Smith B, Steel C, Evans J, et al. Trauma and hallucinatory experience in psychosis. J Nerv Ment Dis. 2005;193(8):501–7. pmid:16082293
- 92. Raune D, Bebbington P, Dunn G, Kuipers E. Event attributes and the content of psychotic experiences in first-episode psychosis. Psychol Med. 2006;36(2):221–30.
- 93. Reiff M, Castille DM, Muenzenmaier K, Link B. Childhood abuse and the content of adult psychotic symptoms. Psychol Trauma Theory Res Pract Policy. 2012;4(4):356–69.
- 94. Blanc L, Askenazy F, Dumas LE. Clinique des hallucinations acoustico-verbales chez les enfants et les adolescents dans les suites d’un trouble de stress post-traumatique: illustration en cas cliniques. Neuropsychiatr Enfance Adolesc [Internet]. 8 juill 2021; Disponible sur: https://www.sciencedirect.com/science/article/pii/S022296172100115X
- 95. Brewin CR, Burgess N. Contextualisation in the revised dual representation theory of PTSD: a response to Pearson and colleagues. J Behav Ther Exp Psychiatry. 2014;45(1):217–9. pmid:24041427
- 96. Larøi F, Van der Linden M, Goëb JL. Hallucinations et idées délirantes chez les enfants et adolescents: mise en perspective avec les travaux réalisés chez l’adulte. Neuropsychiatr Enfance Adolesc. 2009;57(1):32–7.
- 97. Livet A, Salomé F. Explications cognitives des hallucinations acoustico-verbales dans la schizophrénie: un article de synthèse de la littérature scientifique. L’Encéphale. 2020;46(3):217–21.
- 98. McCarthy-Jones S. Is Shame Hallucinogenic? Front Psychol. 2017;8:1310.
- 99. Volpato E, Cavalera C, Castelnuovo G, Molinari E, Pagnini F. The “common” experience of voice-hearing and its relationship with shame and guilt: a systematic review. BMC Psychiatry. 2022;22(1):281. pmid:35443637
- 100. Rössler W, Ajdacic-Gross V, Rodgers S, Haker H, Müller M. Childhood trauma as a risk factor for the onset of subclinical psychotic experiences: exploring the mediating effect of stress sensitivity in a cross-sectional epidemiological community study. Schizophr Res. 2016;172(1–3):46–53.
- 101. Bloomfield MAP, Chang T, Woodl MJ, Lyons LM, Cheng Z, Bauer-Staeb C, et al. Psychological processes mediating the association between developmental trauma and specific psychotic symptoms in adults: a systematic review and meta-analysis. World Psychiatry Off J World Psychiatr Assoc WPA. 2021;20(1):107–23.
- 102. Cheng J, Liang Y, Fu L, Liu Z. The relationship between PTSD and depressive symptoms among children after a natural disaster: A 2-year longitudinal study. Psychiatry Res. 2020;292:113296. pmid:32688133
- 103. Rooney EA, Hallauer CJ, Xie H, Shih C-H, Rapport D, Elhai JD, et al. Longitudinal PTSD symptom trajectories: Relative contributions of state anxiety, depression, and emotion dysregulation. J Affect Disord. 2022;308:281–8. pmid:35452754
- 104. Auxéméry Y. Post-traumatic psychiatric disorders: PTSD is not the only diagnosis. Presse Med. 2018;47(5):423–30. pmid:29580906
- 105.
Borsboom D. Mental disorders, network models, and dynamical systems. In: Philosophical issues in psychiatry IV: Classification of psychiatric illness. New York, NY, US: Oxford University Press; 2017. p. 80–97 (International perspectives in philosophy and psychiatry).
- 106. Cramer AOJ, Waldorp LJ, van der Maas HLJ, Borsboom D. Comorbidity: a network perspective. Behav Brain Sci. 2010;33(2–3):137–50; discussion 150-93. pmid:20584369
- 107. Rossi AA, Panzeri A, Fernandez I, Invernizzi R, Taccini F, Mannarini S. The impact of trauma core dimensions on anxiety and depression: a latent regression model through the Post-Traumatic Symptom Questionnaire (PTSQ). Sci Rep. 2024;14(1):23036. pmid:39362897
- 108. Sasson NJ, Pinkham AE. Exploring the Role of Social Cognition in the Relationship Between Trauma and Psychopathology. Biol Psychiatry Cogn Neurosci Neuroimaging. 2018;3(10):822–3. pmid:30297030
- 109. Bartels-Velthuis AA, Blijd-Hoogewys EMA, van Os J. Better theory-of-mind skills in children hearing voices mitigate the risk of secondary delusion formation. Acta Psychiatr Scand. 2011;124(3):193–7. pmid:21426312
- 110. Steenhuis LA, Pijnenborg GHM, van Os J, Aleman A, Nauta MH, Bartels-Velthuis AA. Childhood theory of mind does not predict psychotic experiences and social functioning in a general population sample of adolescents. PLoS One. 2019;14(2):e0213165. pmid:30818390
- 111. Mollon J, David AS, Zammit S, Lewis G, Reichenberg A. Course of Cognitive Development From Infancy to Early Adulthood in the Psychosis Spectrum. JAMA Psychiatry. 2018;75(3):270–9. pmid:29387877
- 112. Fusar-Poli P. The Clinical High-Risk State for Psychosis (CHR-P), Version II. Schizophr Bull. 2017;43(1):44–7. pmid:28053129
- 113. Rose L. Évaluer la cognition sociale chez l’enfant: état des lieux et enjeux. Rev Neuropsychol. 2023;15(2):109–13.
- 114. Fares-Otero NE, Schalinski I. Social cognition in maltreated individuals: Do type and timing of maltreatment matter? Eur Neuropsychopharmacol. 2024;81:38–40. pmid:38324938